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Abstract Most drug-metabolizing phase I and phase II
enzymes, including the glutathione S-transferases (GST), exhibit
a zonated expression in the liver, with lower expression in the
upstream, periportal region. To elucidate the involvement of
pituitary-dependent hormones in this zonation, the effect of
hypophysectomy and 3,3P,5-triiodo-L-thyronine (T3) on the
distribution of GST was studied in rats. Hypophysectomy
increased total GST activity both in the periportal and
perivenous liver region. Subsequent T3 treatment counteracted
this effect in the perivenous zone. However, analysis for either W
class M1/M2-specific (1,2-dichloro-4-nitrobenzene) or K class
A1/A2-specific (7-chloro-4-nitrobenzo-2-oxa-1,3-diazole) GST
activity revealed that T3 treatment did not significantly affect
the perivenous activity of these GST classes. In contrast, T3 was
found to significantly counteract the increase of K class GST
activity caused by hypophysectomy in the periportal zone. To
establish whether this effect was T3-specific, hepatocytes were
isolated from either the periportal and perivenous zone by
digitonin/collagenase perfusion and cultured either as pyruvate-
supplemented monolayer or as co-culture with rat liver epithelial
cells. Only in the latter it was found that T3 suppressed the A1/
A2-specific GST activity and K class proteins predominantly in
periportal cells. The data demonstrate that T3 is an important
factor responsible for the low expression of K GST in the
periportal region. T3 may be involved in the periportal down-
regulation of other phase I and II enzymes as well. ß 2001
Federation of European Biochemical Societies. Published by
Elsevier Science B.V. All rights reserved.
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1. Introduction
It is well known that many liver genes, including those
encoding phase I and phase II biotransformation enzymes,
are expressed in a zone-speci¢c manner across the hepatic
acinus, the microcirculatory unit of the liver [1,2]. This zo-
nated enzyme expression is thought to be directed by gra-
dients of oxygen, hormones and other mediators, such as
substrates and metabolites, that are formed in the blood
streaming along the hepatic sinusoids [1,2]. Members of the
phase II glutathione S-transferase (GST; EC 2.5.1.18) family
are predominantly expressed in the perivenous liver region
[1,3^5], the area more vulnerable to xenobiotics [1,6,7]. Con-
sequently, understanding the factors that control the hetero-
geneous expression pattern may reveal mechanisms of zone-
speci¢c liver damage [2].
Although endogenous hepatic GST regulation has been
studied both in vivo [8^12] and in vitro [13,14], the hormonal
regulation of the zonated expression of GST and other bio-
transformation enzymes has received limited attention.
Growth hormone and triiodothyronine (T3) have been found
to regulate the zonal expression pattern of the phase I P450
cytochromes (CYPs) 2B and CYP3A genes. The e¡ect of T3
was, however, found to be subgroup- or even isoenzyme-spe-
ci¢c. For instance, T3 strongly suppressed CYP3A1/2 exclu-
sively in the periportal region, whereas CYP2B1/2 was equally
reduced in both regions [6,15,16]. Since it has been shown
both in vivo [10,11] and in vitro [13,14] that T3 is involved
in the overall regulation of hepatic GST isoenzymes, we in-
vestigated whether T3 also controls their regional distribution.
Therefore, in this paper, the e¡ects of hypophysectomy and
subsequent T3 treatment on the in vivo zonation of GST
activities were studied by analyzing periportal and perivenous
cell lysates obtained after zone-restricted digitonin pulse infu-
sion during in situ liver perfusion. The data were compared
with in vitro studies based on isolation of periportal and peri-
venous rat hepatocytes followed by their culture either as py-
ruvate-supplemented monolayer [17] or as co-culture with bile
duct epithelial cells [18].
2. Materials and methods
2.1. Chemicals
Crude collagenase type I, bovine serum albumin fraction V, insulin,
digitonin, L-glutamine, ethacrynic acid (EA), EDTA, guanidinehydro-
chloride, pyruvate and epoxy-activated Sepharose 6B were purchased
from Sigma Chemical Co. (St. Louis, MO, USA). William’s medium
E (without L-glutamine), fetal bovine serum (FBS) and trypsin-EDTA
solution were from Gibco BRL (Brussels, Belgium), hydrocortisone
hemisuccinate from Upjohn s.a. (Puurs, Belgium) and amfotericin B
from Bristol-Myers-Squibb Belgium n.v. (Brussels, Belgium). 1-
Chloro-2,4-dinitrobenzene (CDNB) and 1,2-dichloro-4-nitrobenzene
(DCNB) were from Merck Belgolabo (Darmstadt, Germany), 7-
chloro-4-nitrobenzo-2-oxa-1,3-diazole (NBD-Cl) and hydroxypropyl-
L-cyclodextrin (HPBC, Encapsin1 HPB, 30.221.54) from Janssen
Chimica (Beerse, Belgium), glutathione from Boehringer Mannheim
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(Germany) and 3,3P,5-triiodo-L-thyronine (T3) from Fluka Chemie
(Bornem, Belgium). All other chemicals were readily available com-
mercial products.
2.2. Animals
Hypophysectomized and sham-operated outbred male Sprague
Dawley rats were obtained from MÖllegaard, Ejby, Denmark. The
rats were hypophysectomized or sham-operated at the age of 5 or
7 weeks and allowed to stabilize for 1 week. The rats received bupre-
norphin (Temgesic 0.3 mg/ml) at 0.15 mg/kg immediately after sur-
gery. The animals were fed a commercial R3 laboratory diet (Ewos,
So«derta«lje, Sweden) and water ad libitum. The animals were: (a) con-
trols (sham-hypophysectomized rats, (b) hypophysectomized rats and
(c) hypophysectomized rats injected daily intraperitoneal with T3
(50 Wg/kg) for the last 7 days. The e¡ect of hypophysectomy and T3
treatment was monitored by weighing the rats. All animal experiments
were approved by the Institutional Animal Care and Use Committee
at Alko-Group Ltd., Finland.
2.3. Collection of periportal and perivenous cell lysates
Periportal and perivenous cell lysates were obtained during in situ
digitonin perfusion as described previously [15]. Brie£y, periportal
cells were lysed by infusion of 3.5 mM digitonin via the vena porta
and the lysate was collected by immediate retrograde £ushing. Sub-
sequently, perivenous cell lysates were obtained by infusing digitonin
via the upper vena cava followed by antegrade £ushing. The length of
the digitonin pulse, which determines the penetration depth, was em-
pirically determined to allow the digitonin to lyse approximately one-
fourth to one-third of the cells along the plate in either the proximal
or distal part of the sinusoid. The activity of the periportal marker
enzyme alanine aminotransferase (EC 2.6.1.2), which was assayed to
verify the zone-speci¢city of the cell lysates [16], was found to be 7.6-
fold higher in periportal samples than in perivenous samples, indicat-
ing clear acinar separation [6]. For GST activity measurements, ali-
quots (200 Wl) of cell lysates were immediately frozen in liquid nitro-
gen and stored at 380‡C until assayed.
2.4. Isolation and culture of periportal and perivenous rat hepatocytes
Intact hepatocytes from outbred adult male Sprague Dawley rats
weighing 200^250 g (I¡a Credo Brussels, Belgium) were isolated from
either the periportal or the perivenous region of the liver acinus by
using zone-speci¢c destruction with digitonin infusion as described
above, followed by collagenase perfusion and isolation of cells from
the intact acinar regions [19,20]. The activity of the perivenous marker
enzyme glutamine synthetase (GS; EC 6.3.1.2) was assayed [21] to
verify the zone-speci¢city of the freshly isolated hepatocytes [1,21].
GS activity in freshly isolated perivenous hepatocytes was 33-fold
higher than in periportal cells, which is in agreement with previous
studies [22,23] and thus demonstrates the di¡erent acinar origin of the
cell populations to be cultured. After testing for cell integrity by
trypan blue exclusion, hepatocytes were seeded in medium containing
10% FBS (v/v). After 4 h incubation at 37‡C in an atmosphere of 95%
air and 5% CO2 at a relative humidity of 100%, monolayer cultures
[17] and co-cultures with rat liver epithelial cells of primitive biliary
origin [24] were set up. 24 h after cell plating and every day thereafter,
all cultures were incubated with serum-free medium supplemented
with 0.1 WM T3 incorporated in 0.02% w/v HPBC (¢nal concentra-
tion) in phosphate-bu¡ered saline [14]. Control cultures contained
0.02% (w/v) of the delivery system alone. The vehicle HPBC has no
e¡ect on GST expression [14]. Samples were taken at days 4 and 7 of
culture.
2.5. GST isoenzyme activities
The GST activity was measured spectrophotometrically using
CDNB and DCNB as broad spectrum and W class M1/M2-speci¢c
substrates, respectively [25]. The K A1/A2-speci¢c and Z class GST
activities were determined using NBD-Cl [26] and EA [27] as sub-
strates.
Table 1
E¡ect of T3 on GST activities measured by CDNB, DCNB, NBD-Cl and EA in periportal and perivenous rat hepatocytes either cultured as
pyruvate-supplemented monolayer or co-cultured with rat liver epithelial cells for 4 days
Substrate GST isoenzyme activities (% of control value)
Co-culture Pyruvate-supplemented monoculture
Periportal Perivenous Periportal Perivenous
CDNB 74.9 þ 5.3* 106.0 þ 4.4 89.2 þ 16.4 89.8 þ 25.1
DCNB 99.0 þ 12.4 75.2 þ 17.2 82.4 þ 4.0 109.7 þ 15.1
NBD-Cl 53.9 þ 5.7** 103.7 þ 14.1 86.2 þ 16.2 91.5 þ 7.1
EA 94.0 þ 27.4 74.3 þ 4.0 83.2 þ 7.9 99.9 þ 3.7
Mean values þ S.D. of three independent periportal and perivenous culture experiments are presented. Statistical di¡erence between correspond-
ing periportal or perivenous control values (0.02% w/v HPBC) is given by * or ** for P6 0.05 or P6 0.01, respectively (unpaired Student’s
t-test).
Table 2
E¡ect of T3 on the GST subunit pro¢le of periportal and perivenous rat hepatocytes either cultured as pyruvate-supplemented monolayer or
co-cultured with rat liver epithelial cells for 4 days
Subunits Subunit concentration (Wg/mg cytosolic protein)
Periportal Perivenous Periportal Perivenous
Control T3-treated Control T3-treated Control T3-treated Control T3-treated
K Class
A1 4.9 þ 2.1 1.7 þ 0.1* 3.4 þ 1.1 2.7 þ 0.6 6.3 þ 1.3 5.8 þ 0.3 6.7 þ 0.7 7.1 þ 0.6
A2 2.2 þ 0.5 2.0 þ 0.4 1.8 þ 1.0 2.9 þ 0.8 5.2 þ 1.3 5.1 þ 0.3 5.7 þ 1.1 5.0 þ 2.0
A3 2.7 þ 0.6 1.4 þ 0.1* 2.3 þ 1.8 2.5 þ 1.0 4.7 þ 2.4 5.6 þ 0.1 5.5 þ 0.5 4.8 þ 1.2
Subtotal 10.7 þ 3.7 5.5 þ 0.7* 7.8 þ 3.2 8.5 þ 1.2 16.9 þ 2.4 17.0 þ 0.6 18.6 þ 1.7 17.4 þ 6.3
W Class
M1 4.2 þ 2.4 2.6 þ 1.4 4.5 þ 2.9 5.0 þ 1.7 6.0 þ 1.1 5.3 þ 0.5 7.3 þ 0.5 7.0 þ 2.6
M2 6.0 þ 3.3 3.2 þ 1.6 6.6 þ 3.1 7.2 þ 1.3 4.6 þ 1.7 3.3 þ 0.6 7.2 þ 0.8 4.6 þ 4.3
M3 0.4 þ 0.2 0.2 þ 0.1 0.3 þ 0.1 0.3 þ 0.2 0.3 þ 0.2 0.3 þ 0.1 0.2 þ 0.2 0.3 þ 0.3
Subtotal 10.5 þ 5.6 6.0 þ 3.1 11.4 þ 6.0 12.5 þ 2.8 11.0 þ 2.6 8.8 þ 1.2 14.7 þ 1.5 11.9 þ 6.9
Z Class
P1 5.1 þ 1.0 3.3 þ 0.2* 5.0 þ 1.3 6.3 þ 0.2 4.6 þ 3.2 4.7 þ 0.8 8.0 þ 2.7 6.5 þ 1.0
Total 26.3 þ 10.6 14.8 þ 3.9 24.3 þ 10.1 27.2 þ 3.8 32.5 þ 4.1 30.5 þ 1.0 41.3 þ 4.6 35.9 þ 12.9
Mean values þ S.D. of three independent periportal and perivenous culture experiments are presented. Statistical di¡erence between correspond-
ing periportal or perivenous control values (0.02% w/v HPBC) is given by * for P6 0.05 (unpaired Student’s t-test).
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The protein contents in the cell lysates and the cytosolic fractions of
freshly isolated and co-cultured periportal and perivenous hepatocytes
were measured using a ‘Bio-Rad protein assay kit’ (Bio-Rad, Brussels,
Belgium) with bovine serum albumin as a standard. To be able to
express the results versus hepatocyte proteins, correction for the help-
er epithelial cell proteins was carried out as described previously [28].
2.6. High performance liquid chromatography (HPLC) analysis of
GST subunits
GST proteins were determined by reversed phase HPLC [29], after
puri¢cation of the samples with a⁄nity chromatography on a gluta-
thione-Sepharose 6B column as described earlier [30,31].
3. Results and discussion
3.1. E¡ect of hypophysectomy and T3 treatment on zonation of
GST isoenzyme activities
In agreement with previous results obtained by our groups
[3,31], we found a general perivenous dominance (P6 0.01) of
GST activities measured by CDNB, DCNB and NBD-Cl in
control cell lysates. After hypophysectomy, CDNB and
DCNB activities were increased equally in both liver regions
(increases of 35% and 25%, respectively) (Fig. 1). Conse-
quently, the perivenous/periportal ratio for both GST activ-
ities remained unaltered. Treatment of hypophysectomized
rats with T3 restored the CDNB activity partially and the
DCNB activity totally, to control levels. However, no zone-
speci¢c e¡ect of T3 on CDNB or DCNB activity was ob-
served. In contrast, hypophysectomy increased the NBD-Cl
activity, which re£ects the K class A1/A2 activity, 2-fold
more in the periportal than the perivenous zone. This resulted
in a signi¢cantly (P6 0.05) decreased perivenous/periportal
ratio as compared to controls. T3 treatment completely re-
stored the NBD-Cl activity both in periportal and perivenous
regions to those observed in controls (Fig. 1). Consequently,
the perivenous/periportal ratio was also normalized
(P6 0.05). Thus, although hypophysectomy and subsequent
T3 treatment a¡ect the overall expression of GST similarly
in both zones, the e¡ect on GST K A1/A2 activity appears
to be zone-speci¢c.
3.2. E¡ect of T3 treatment on zonation of GST isoenzyme
expression in cultures of periportal and perivenous rat
hepatocytes
To establish the speci¢city of the T3 e¡ect observed in vivo,
periportal and perivenous rat hepatocytes were isolated and
investigated during culture. Hepatocytes were cultured either
in the presence of pyruvate [17] or together with bile duct
epithelial cells [18].
In freshly isolated perivenous hepatocyte populations, high-
er levels of CDNB (P6 0.05), DCNB (P6 0.05) and NBD-Cl
(not signi¢cant) enzyme activities were measured as compared
to freshly isolated periportal cells (Figs. 2 and 3). In contrast
to monocultures (Fig. 3), hepatocytes in co-culture maintained
their in vivo periportal6 perivenous CDNB, DCNB and
NBD-Cl activity di¡erences for up to 4 days (Fig. 2). These
di¡erences disappeared, however, after 7 days. Results ob-
tained by using EA as substrates suggested that the Z class
GST is equally distributed in the acinus.
Exposure of periportal and perivenous hepatocyte co-cul-
tures to T3 for 4 days (Table 1) clearly decreased the CDNB
activity in periportal cell cultures, as a consequence of a 50%
reduction (P6 0.01) of the A1/A2 activity. This ¢nding cor-
responds well with the in vivo e¡ect of T3 on periportal NBD-
Cl activity, described earlier. As a result of the decrease in
NBD-Cl activity in the periportal region, the NBD-Cl activity
was twice as high (P6 0.05) in T3-treated perivenous hepato-
cytes. These data were con¢rmed by HPLC analysis of GST
subunits (Table 2). In periportal co-cultures treated with T3,
the amount of K class proteins was reduced to about 50% as
compared to corresponding controls, mainly due to signi¢cant
Fig. 1. GST activities measured by CDNB (broad spectrum),
DCNB (W class M1/M2-speci¢c) and NBD-Cl (K class A1/A2-specif-
ic) in periportal (pp) and perivenous (pv) cell lysates of male adult
rat liver under control conditions (C) and after hypophysectomy
(Hx) and subsequent T3 treatment (Hx+T3). Results are expressed
as means þ S.D. (n = 5 for each treatment group). Values above the
bars indicate pv/pp ratios. Statistical di¡erence between pp and pv
values within the treatment group, as calculated by the paired Stu-
dent’s t-test, is given by *, ** or *** for P6 0.05, P6 0.01 or
P6 0.001, respectively. Statistical di¡erence between Hx or Hx+T3
values and control values from a similar acinar region is given by
3 or 33 for P6 0.05 or P6 0.01, respectively (unpaired Student’s
t-test). Statistical di¡erence between Hx and Hx+T3 values from the
same acinar region is given by or for P6 0.05 or P6 0.01, re-
spectively (unpaired Student’s t-test).
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e¡ects on subunits A1 and A3 (P6 0.05). Importantly, T3
treatment had no e¡ect on co-cultured perivenous hepato-
cytes.
The absence of e¡ects of T3 treatment on GST isoenzyme
activities (Table 1) or subunits (Table 2) in hepatocytes grown
in pyruvate-supplemented monocultures con¢rms previous
observations that responsiveness to T3 is maintained in co-
cultures [13,32] but not in monocultures [33,34]. This demon-
strates the importance of using the correct culture conditions
for studies of in vivo phenomena during in vitro conditions.
Previous in vivo studies on hormonal gradients are scarce.
There are reports on gradients for the growth factor EGF and
several hormones, including insulin, glucagon and thyroxine
[1,2]. However, the interpretation of zonal e¡ects of hormones
is complicated by their binding to speci¢c serum proteins and
by the complex relation between their uptake and degradation
in the sinusoid [1,2].
To our knowledge, periportal and perivenous rat hepato-
cytes co-cultured with epithelial cells have not been investi-
gated previously. This model should provide a useful in vitro
model for studying hormonal control of zonated expression of
Fig. 2. GST activities measured by CDNB (broad spectrum),
DCNB (W class M1/M2-speci¢c) and NBD-Cl (K class A1/A2-specif-
ic) in periportal (pp) and perivenous (pv) rat hepatocytes co-cul-
tured with rat liver epithelial cells for 7 days. Mean values þ S.D. of
three independent pp and pv culture experiments are presented. Sta-
tistical di¡erence between corresponding pp and pv values is given
by * or ** for P6 0.05 or P6 0.01, respectively (unpaired Student’s
t-test).
Fig. 3. GST activities measured by CDNB (broad spectrum),
DCNB (W class M1/M2-speci¢c) and NBD-Cl (K class A1/A2-specif-
ic) in 7-day-old pyruvate-supplemented monolayer cultures of peri-
portal (pp) and perivenous (pv) rat hepatocytes. Mean values þ S.D.
of three independent pp and pv culture experiments are presented.
Statistical di¡erence between corresponding pp and pv values is giv-
en by * for P6 0.05 (unpaired Student’s t-test).
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liver genes. Our data strongly suggest that T3 downregulates
the expression of GST K proteins, in particular GSTA1 and
GSTA3, and that this explains the low GST activity in the
periportal liver region. The zone-speci¢city of this e¡ect sug-
gests the existence of a sinusoidal gradient, either of T3 uptake
or of the T3 receptor. The fact that the periportal responsive-
ness to T3 is maintained in isolated cells suggests that the T3
receptor is expressed predominantly in the periportal region.
Alternatively, T3 might speci¢cally a¡ect some GST K regu-
lating transcription factor(s) that are unevenly distributed
within the hepatic acinus.
In conclusion, the present results show that T3 downregu-
lates the periportal expression of GST K, while other GST
subunits are una¡ected. We hypothesize that T3 also is re-
sponsible for other liver genes that exhibit lower expression
in the periportal region.
Acknowledgements: The authors gratefully thank Mrs. G. De Pauw,
Mrs. E. Desmedt, Ms. Gunilla Ro«nnholm, Ir. Andre¤ Callaerts and Ir.
Walter Sonck for their skilful technical assistance. This work was
supported by grants from the National Fund for Scienti¢c Research
(FWO), Belgium, and the Research Council (OZR) of the Vrije Uni-
versiteit Brussel, Belgium.
References
[1] Gebhardt, R. (1992) Pharmacol. Ther. 53, 275^354.
[2] Oinonen, T. and Lindros, K.O. (1998) Biochem. J. 329, 17^35.
[3] Kera, Y., Sippel, H., Penttila«, K.E. and Lindros, K.O. (1987)
Biochem. Pharmacol. 36, 2003^2006.
[4] Redick, J.A., Jakoby, W.B. and Baron, J. (1982) J. Biol. Chem.
257, 15200^15203.
[5] Sippel, H., Lindros, K.O. and Oinonen, T. (1996) Pharmacol.
Toxicol. 79, 80^86.
[6] Oinonen, T., Mode, A., Lobie, P.E. and Lindros, K.O. (1996)
Biochem. Pharmacol. 51, 1379^1387.
[7] Lindros, K.O. (1997) Gen. Pharmacol. 28, 191^196.
[8] Mankowitz, L., Castro, V.M., Mannervik, B., Rydstro«m, J. and
DePierre, J.W. (1990) Biochem. J. 265, 147^154.
[9] Sta¡as, L., Mankowitz, L., So«derstro«m, M., Blanck, A., Porsch-
Ha«llstro«m, I., Sundberg, C., Mannervik, B., Olin, B., Rydstro«m,
J. and Depierre, J.W. (1992) Biochem. J. 286, 65^72.
[10] Kelley, M.K. and Bjeldanes, L.F. (1995) Food Chem. Toxicol.
33, 129^137.
[11] Beckett, G.J., Boyd, R., Beddows, S.E. and Hayes, J.D. (1988)
Biochem. Pharmacol. 37, 3201^3204.
[12] Meyer, D.J., Harris, J.M., Gilmore, K.S., Coles, B., Kensler,
T.W. and Ketterer, B. (1993) Carcinogenesis 14, 567^572.
[13] Coecke, S., Vanhaecke, T., Foriers, A., Phillips, I.R., Vercruysse,
A., Shephard, E.A. and Rogiers, V. (2000) J. Endocrinol. 166,
363^371.
[14] Vanhaecke, T., Derde, M.-P., Vercurysse, A. and Rogiers, V.
(2000) Biochem. Pharmacol. (in press).
[15] Oinonen, T., Nikkola, E. and Lindros, K.O. (1993) FEBS Lett.
327, 237^240.
[16] Oinonen, T. and Lindros, K.O. (1995) Biochem. J. 309, 55^61.
[17] Vanhaecke, T., Vercruysse, A. and Rogiers, V. (1997) Toxicol. In
Vitro 11, 435^441.
[18] Guguen-Guillouzo, C., Cle¤ment, B., Ba¡et, G., Beaumont, C.,
Morel-Chany, E., Glaise, D. and Guillouzo, A. (1983) Exp.
Cell Res. 43, 47^54.
[19] Lindros, K.O. and Penttila«, K.E. (1985) Biochem. J. 228, 757^
760.
[20] Quistro¡, B. (1985) Biochem. J. 229, 221^226.
[21] Gebhardt, R. (1998) Isolation of periportal and pericentral hepa-
tocytes, in: Cytochrome P450 Protocols. Series in: Methods in
Molecular Biology (Phillips, I.R. and Shephard, E.A., Eds.), Vol.
107, pp. 319^339, Humana Press Inc., Totowa, NJ.
[22] Gebhardt, R., Gaunitz, F. and Mecke, D. (1994) Adv. Enz. Reg.
34, 27^56.
[23] Quistor¡, B. and Grunnet, N. (1987) Biochem. J. 243, 87^95.
[24] Vanhaecke, T., De Smet, K., Beken, S., Pauwels, M., Vercruysse,
A. and Rogiers, V. (1998) Rat hepatocyte cultures. Conventional
monolayer cultures and cocultures with rat liver epithelial cells,
in: Cytochrome P450 Protocols. Series in: Methods in Molecular
Biology (Phillips, I.R. and Shephard, E.A., Eds.), Vol. 107, pp.
311^317, Humana Press Inc., Totowa, NJ.
[25] Habig, W.H., Pabst, M.J. and Jakoby, W.B. (1974) J. Biol.
Chem. 249, 7130^7139.
[26] Ricci, G., Caccuri, A.M., Lo Bello, M., Pastore, A., Piemonte, F.
and Federici, G. (1994) Anal. Biochem. 218, 463^465.
[27] Habig, W.H. and Jakoby, W.B. (1981) Methods Enzymol. 77,
398^405.
[28] Rogiers, V., Vandenberghe, Y., Callaerts, A., Verleye, G., Cor-
net, M., Mertens, K., Sonck, W. and Vercruysse, A. (1990) Bio-
chem. Pharmacol. 40, 1701^1706.
[29] Vandenberghe, Y., Foriers, A., Rogiers, V. and Vercruysse, A.
(1990) Biochem. Pharmacol. 39, 685^690.
[30] Vandenberghe, Y., Glaise, D., Meyer, D.J., Guillouzo, A. and
Ketterer, B. (1988) Biochem. Pharmacol. 37, 2482^2485.
[31] Vanhaecke, T., Lindros, K.O., Oinonen, T., Vercruysse, A. and
Rogiers, V. (2000) Drug Metab. Dispos. (in press).
[32] Coecke, S., Debast, G., Phillips, I.R., Shephard, E.A. and Ro-
giers, V. (1998) Biochem. Pharmacol. 56, 1047^1051.
[33] Gebhardt, R., Fitzke, H., Fausel, M., Eisenmann-Tappe, I. and
Mecke, D. (1990) Cell Biol. Toxicol. 6, 365^378.
[34] Nishii, Y., Hashizume, K., Ichikawa, K., Takeda, T., Kobayashi,
M., Nagasawa, T., Katai, M., Kobayashi, H. and Sakurai, A.
(1993) Endocr. J. 40, 399^404.
FEBS 24444 4-1-01
T. Vanhaecke et al./FEBS Letters 487 (2001) 356^360360
